PG F2alpha receptor: a promising therapeutic target for cardiovascular disease
Prostaglandins (PGs), a group of key lipid mediators, are involved in numerous physiological and pathological processes including inflammation and cardiovascular homeostasis. Each PG acts on its specific and distinct cell surface G protein coupled receptors (GPCR) or peroxisome proliferator-activate...
Main Authors: | Jian Zhang, Yanjun Gong, Ying Yu |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2010-10-01
|
Series: | Frontiers in Pharmacology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/Journal/10.3389/fphar.2010.00116/full |
Similar Items
-
Modulation allostérique du récepteur FP dans le cancer colorectal
by: Tassy, Danaë
Published: (2016) -
Prostaglandin E2 Signaling Through Kidney EP1 and EP4 Receptors; Implications in Diabetes and Hypertension
by: Thibodeau, Jean-François
Published: (2015) -
Students using isolated uterine and other preparations show bimatoprost and prostanoid FP agonists have differently activated profiles
by: Marshall, Kay M., et al.
Published: (2009) -
Cardiac effects of prostaglandins E₁ and F₁α
by: Vadlamudi, Rao Venkata Satya Veerabhadra
Published: (2010) -
Scavenger Receptors as Biomarkers and Therapeutic Targets in Cardiovascular Disease
by: Gary A. Cuthbert, et al.
Published: (2020-11-01)